A new comprehensive review has found that mindfulness-based cognitive therapy (MBCT) can bring measurable improvements to mental well-being and brain function, strengthening its case as a mainstream treatment for stress-related disorders. The findings suggest MBCT may offer benefits beyond symptom reduction, influencing how the brain regulates emotion and cognition.
The review, published in the Journal of Clinical Medicine, synthesised data from 87 studies covering the impact of MBCT on mental health outcomes and neurocognitive function. Originally designed to prevent depressive relapse, MBCT is now being used more widely to treat a range of psychological conditions. It combines traditional cognitive therapy techniques with mindfulness practices to help individuals manage negative thoughts and emotional responses.
Researchers found that MBCT consistently reduced symptoms of depression, anxiety, and chronic stress across diverse groups, including patients with recurrent depression, carers of people with dementia, and individuals managing chronic illnesses. In some cases, benefits were still observed months after the intervention ended.
But the most striking findings were linked to changes in the brain. The review found that MBCT may lead to neuroplasticity – the brain’s ability to reorganise and form new connections. Structural and functional changes were observed in regions associated with emotion regulation, such as the prefrontal cortex and amygdala. Enhanced connectivity in brain networks responsible for attention and self-awareness was also reported, supporting the idea that MBCT helps individuals adopt healthier cognitive patterns.
These neurological effects were tied to improvements in subjective well-being. Participants reported greater life satisfaction, emotional balance, and a heightened sense of purpose. The therapy appeared to encourage more adaptive thinking by helping individuals distance themselves from repetitive negative thoughts.
While MBCT draws from Buddhist meditation practices, it is presented in a secular format. The standard MBCT programme typically runs over eight weeks and includes group sessions with guided mindfulness exercises. Participants learn to observe their thoughts without judgement and to redirect attention to the present moment.
The review also highlighted MBCT’s relevance in workplace settings and among healthcare professionals, with evidence suggesting it reduces emotional exhaustion and improves resilience. Trials among older adults and young people showed promising effects on memory, executive function, and emotional control, pointing to the therapy’s cross-generational appeal.
Though results across studies were mostly positive, researchers called for greater methodological consistency in future trials. They also stressed the need for longer-term studies to understand how enduring the benefits of MBCT might be and how it compares to other therapies such as cognitive behavioural therapy.
Still, this review strengthens the scientific foundation for mindfulness-based therapy as a credible intervention for mental health. It also raises important questions about how cognitive training methods could be tailored to individual neurological profiles.
